Respiri Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.01 |
Market Cap |
AUD52.59 M |
Shares Outstanding |
525.88 M |
Public Float |
512.79 M |
Address |
446 Collins Street Melbourne Victoria (VIC) 3000 Australia |
Employees | - |
Website | http://www.respiri.com.au |
Updated | 07/08/2019 |
Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. It operates through the Australia and Israel segments. |